Liwag Terrin, Wong Kindchia, Martinez Eladio, Nguyen Steven
Internal Medicine, Western University of Health Sciences, Pomona, USA.
Family Medicine, Western University of Health Sciences, Pomona, USA.
Cureus. 2022 May 15;14(5):e25028. doi: 10.7759/cureus.25028. eCollection 2022 May.
We present a unique case of a 60-year-old male with congestive heart failure who was admitted for a pre-syncopal episode and found to be in atrial fibrillation with rapid ventricular response (RVR). In order to effectively rate control the patient, he was administered an amiodarone bolus and intravenous (IV) infusion over 24 hours, along with a single oral 200 mg dose the following day. The patient subsequently developed acute hepatotoxicity along with features of acute kidney injury (AKI), pulmonary distress, and leukocytosis. After ruling out other etiologies for acute liver, pulmonary, and kidney injury, amiodarone-induced multi-organ toxicity was suspected and amiodarone was discontinued. Within hours of amiodarone discontinuation, the patient's clinical status and organ function improved remarkably. In the setting of a patient being treated with IV amiodarone and presenting with sudden signs of dyspnea, acute elevation of transaminases and AKI within one to two days of initial dosing, acute amiodarone-induced organ toxicity should be considered.
我们报告了一例独特的病例,一名60岁男性充血性心力衰竭患者因晕厥前发作入院,检查发现为快速心室率的心房颤动(RVR)。为有效控制该患者的心率,给予其胺碘酮推注并在24小时内静脉输注,次日给予单次口服200 mg剂量。该患者随后出现急性肝毒性以及急性肾损伤(AKI)、肺窘迫和白细胞增多的症状。在排除急性肝、肺和肾损伤的其他病因后,怀疑是胺碘酮引起的多器官毒性,遂停用胺碘酮。停用胺碘酮数小时内,患者的临床状况和器官功能显著改善。对于接受静脉胺碘酮治疗且在初始给药后一至两天内突然出现呼吸困难、转氨酶急性升高和AKI症状的患者,应考虑急性胺碘酮引起的器官毒性。